Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...] …
Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...] …
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...] …
California state senators yesterday abruptly pulled a 340B contract pharmacy access bill from a scheduled hearing just days before a [...] …
A federal district judge has dismissed AbbVie’s lawsuit challenging Missouri’s 340B contract pharmacy access law, marking another legal setback for [...] …
Four large drugmakers recently filed a pair of new briefs in their ongoing appeals of legal rulings that upheld the [...] …
A major brand-name drug industry trade group has sued Hawaii over its new law prohibiting pharmaceutical manufacturers from restricting 340B [...] …